Logo

PharmaShots Weekly Snapshot (Jun 29 - Jul 03, 2020)

Share this

PharmaShots Weekly Snapshot (Jun 29 - Jul 03, 2020)

 

1. Medivir’s MIV-818 Receives EC’s Orphan Medicinal Product Designation to Treat Hepatocellular Carcinoma

Published: Jul 03, 2020 | Tags: EC, Hepatocellular Carcinoma, Medivir, Miv-818, Orphan, Medicinal Product Designation, Receives

2. ViiV Healthcare’s Rukobia (fostemsavir) Receives the US FDA’s Approval for HIV in Patients with Limited Treatment Options

Published: Jul 03, 2020 | Tags: Approval, FDA, Fostemsavir, HIV, Limited, Treatment, Options, Patients, Receives, Rukobia, US, Viiv Healthcare

3. Sanofi and Regeneron’s Kevzara (sarilumab) Fails in P-III Trial for Patients with COVID-19 in the US

Published: Jul 03, 2020 | Tags: COVID-19, Fails, Kevzara, P-III, Patients, Regeneron, Sanofi, Sarilumab, Study, US

4. Zydus to Initiate Clinical Trials Evaluating ZyCoV-D Vaccine Against COVID-19 in July 2020

Published: Jul 03, 2020 | Tags: Zydus, Initiate, Clinical Trials, Evaluating, ZyCoV-D, Vaccine, Against, COVID-19, July 2020

5. Sarepta Signs an Exclusive Worldwide License with Hansa to Develop Imlifidase for Duchenne Muscular Dystrophy and Limb-Girdle Muscular Dystrophy

Published: Jul 03, 2020 | Tags: Sarepta, Signs, Exclusive, Worldwide, License, Hansa, Develop, Imlifidase, Duchenne Muscular Dystrophy, Limb-Girdle Muscular Dystrophy

6. Helsinn and MEI Terminate its P-III Study of Pracinostat for Patients with AML

Published: Jul 03, 2020 | Tags: Helsinn, MEI, Terminate, P-III, Study, Pracinostat, Patients, AML

7. Biogen Signs a License Agreement with Massachusetts Eye and Ear to Develop Treatment for Inherited Retinal Disorder

Published: Jul 02, 2020 | Tags: Biogen, Signs, License Agreement, Massachusetts Eye and Ear, Develop, Treatment, Inherited Retinal Disorder

8. Yuhan Collaborates with GI Innovation for its Allergy Treatment Worth up to $1.2B

Published: Jul 02, 2020 | Tags: Yuhan, Collaborates, GI Innovation, Allergy Treatment, Worth, $1.2B

9. Janssen Receives EC’s Approval for its Ebola Vaccine Dual Regimen

Published: Jul 02, 2020 | Tags: Janssen, Receives, EC, Approval, Ebola Vaccine, Dual Regimen

10. Sorrento Selects T-VIVA-19 as a Targeted Protein Vaccine Candidate Against COVID-19

Published: Jul 02, 2020 | Tags: Sorrento, Selects, T-VIVA-19, Targeted, Protein Vaccine Candidate, COVID-19

11. Dr. Reddy’s and GRA Collaborate with Fujifilm for Avigan (favipiravir) to Treat COVID-19 Outside Japan  

Published: Jul 02, 2020 | Tags: Dr. Reddy’s, GRA, Collaborate, Fujifilm, Avigan, Favipiravir, Treat, COVID-19, Outside, Japan

12. Pfizer and BioNTech Report Results of BNT162b1 mRNA-Based Vaccine in P-I/II Study Against COVID-19

Published: Jul 02, 2020 | Tags: Pfizer, BioNTech, Report, Results, BNT162b1, mRNA-Based Vaccine, P-I/II, Study, Against, COVID-19

13. QurAlis Signs a License Agreement with Eli Lilly for its ALS Therapeutic Candidates

Published: Jul 02, 2020 | Tags: QurAlis, Signs, License Agreement, Eli Lilly, ALS, Therapeutic Candidates   

14. Boston Scientific Receives the US FDA’s 510(k) Clearance for its LUX-Dx Insertable Cardiac Monitor System

Published: Jul 01, 2020 | Tags: Boston Scientific, Receives, US, FDA, 510(k) Clearance, LUX-Dx Insertable, Cardiac Monitor System

15. Merck KGaA and Pfizer’s Bavencio (avelumab) Receive the US FDA’s Approval as a 1L Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Published: Jul 01, 2020 | Tags: Merck KGaA, Pfizer, Bavencio, avelumab, Receives, US, FDA, Approval, 1L, Treatment, Locally Advanced, Metastatic Urothelial Carcinoma

16. Samsung Bioepis Reports the Initiation of P-III Study for SB15 Proposed Biosimilar to Eylea (aflibercept)

Published: Jul 01, 2020 | Tags: Aflibercept, Eylea, Initiation P-III, Proposed Biosimilar, Reports, Samsung Bioepis, Sb15, Study

17. G1 Therapeutics and Boehringer Ingelheim Collaborate to Co-Promote Trilaciclib for Small Cell Lung Cancer in the US and Puerto Rico

Published: Jul 01, 2020 | Tags: G1 Therapeutics, Boehringer Ingelheim, Collaborate, Co-Promote, Trilaciclib, Small Cell Lung Cancer, US, Puerto Rico

18. Takeda Collaborates with Carmine for Non-Viral Gene Therapies Worth Up to $900M

Published: Jul 01, 2020 | Tags: Takeda, Collaborates, Carmine, Non-Viral, Gene Therapies, $900M

19. Celltrion’s Remsima SC (biosimilar, infliximab) Receives CHMP’s Positive Opinion for an Additional Five Indications Including Inflammatory Bowel Disease and Ankylosing Spondylitis

Published: Jun 30, 2020 | Tags: Celltrion, Remsima SC, biosimilar, infliximab, Receives, CHMP, Positive Opinion, Additional, Five Indications, Inflammatory Bowel Disease, Ankylosing Spondylitis

20. Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin) Receives the US FDA’s Approval for Early and Metastatic Her2-Positive Breast Cancer

Published: Jun 30, 2020 | Tags: Roche, Phesgo, fixed-dose combination, Perjeta, Herceptin, Receives, US, FDA, Approval, Early, Metastatic, Her2-Positive Breast Cancer 

21. AstraZeneca and MSD’s Selumetinib Receive MHLW’s Orphan Drug Designation for Neurofibromatosis Type 1 in Japan  

Published: Jun 30, 2020 | Tags: AstraZeneca, MSD, Selumetinib, Receives, MHLW, Orphan Drug Designation, Neurofibromatosis Type 1, Japan

22. Bharat Biotech to Initiate Clinical Trials Evaluating Covaxin (India’s First COIVD-19 Vaccine) in July 2020

Published: Jun 30, 2020 | Tags: Bharat Biotech, Initiate, Clinical Trials, Evaluating, Covaxin, India, First, COIVD-19, Vaccine, July 2020

23. Abbott Integrates its CGM Technology with Tandem’s Insulin Delivery System for Improving Diabetes Management

Published: Jun 30, 2020 | Tags: Abbott, Integrate, CGM Technology, Tandem, Insulin Delivery System, Improving, Diabetes Management

24. Gilead Unveils the Price of Remdesivir as $390 per Vial in Developed Countries

Published: Jun 30, 2020 | Tags: Gilead, Unveils, Price, Remdesivir, $390, Vial, US, Developed Countries

25. Samsung Bioepis’ Aybintio (biosimilar, bevacizumab) Receives CHMP’s Positive Opinion to Treat Multiple Cancer Indications

Published: Jun 29, 2020 | Tags: Samsung Bioepis, Aybintio, biosimilar, bevacizumab, Receives, CHMP, Positive Opinion, Treat, Multiple, Cancer Indications

26. Kyowa Kirin’s FKB327 (biosimilar, adalimumab) Receives the MMA Approval in Japan

Published: Jun 29, 2020 | Tags: Kyowa Kirin, FKB32, biosimilar, adalimumab, Receives, the MMA, Approval, Japan

27. Roche’s Enspryng (satralizumab) Receives MHLW’s Approval for Neuromyelitis Optica Spectrum Disorder in Japan

Published: Jun 29, 2020 | Tags: Roche, Enspryng, satralizumab, Receives, MHLW, Approval, Neuromyelitis Optica Spectrum Disorder, Japan

28. Alexion’s Ultomiris (ravulizumab) Receives EC’s Approval for Atypical Hemolytic Uremic Syndrome

Published: Jun 29, 2020 | Tags: Alexion, Ultomiris, ravulizumab, Receives, EC, Approval, Atypical Hemolytic Uremic Syndrome

29. MHLW Approves Novartis’ Five New Therapies Expanding its Footprints in Japan

Published: Jun 29, 2020 | Tags: MHLW, Approves, Novartis, Five New, Therapies, Expanding, Footprints, Japan

30. Daiichi Sankyo in Talks with AstraZeneca for the Supply of AZD1222 to Combat COVID-19 in Japan

    Published: Jun 29, 2020 | Tags: Daiichi Sankyo, Talks, AstraZeneca, Supply, AZD1222, COVID-19,  Japan


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions